Alterations in Sarcoplasmic Reticulum and Mitochondrial Functions in Diabetic Cardiomyopathy
Overview
Affiliations
Although diabetes due to insulin deficiency or insulin resistance is a major cause of heart disease, the pathogenesis of cardiac dysfunction during the development of diabetic cardiomyopathy is not fully understood. Varying degrees of defects in subcellular organelles, such as sarcolemma, mitochondria, sarcoplasmic reticulum, myofibrils and extracellular matrix have been observed in the diabetic heart. These subcellular abnormalities in chronic diabetes become evident with the occurrence of hormonal imbalance, metabolic defects, oxidative stress and intracellular Ca(2+) overload. During the initial stages of diabetes, hormonal imbalances, including elevated plasma levels of catecholamines and angiotensin II, as well as metabolic defects, appear to favour the development of oxidative stress; these changes lead to subcellular defects in the myocardium. Reductions in sarcoplasmic reticular Ca(2+) pump and Ca(2+) release channel function are associated with cardiac dysfunction, whereas alterations in sarcolemmal Na(+)/Ca(2+) exchanger and Na(+)/K(+) ATPase activities contribute to intracellular Ca(2+) overload at late stages of diabetes. The continued accumulation of Ca(2+) in mitochondria produces Ca(2+) overload in these organelles, and this change induces impairment of energy production and depletion of energy stores as well as further promotion of oxidative stress in chronic diabetes. Generation of oxyradicals due to impaired electron transport results in the opening of mitochondrial pores, leakage of toxic proteins and myocardial cell damage in diabetes. These observations support the view that alterations in sarcoplasmic reticular and mitochondrial functions produce intracellular Ca(2+) overload and depletion of energy stores and, thus, play an important role in the development of cardiac dysfunction in diabetic cardiomyopathy.
The interplay of inflammation, exosomes and Ca dynamics in diabetic cardiomyopathy.
Sanganalmath S, Dubey S, Veeranki S, Narisetty K, Krishnamurthy P Cardiovasc Diabetol. 2023; 22(1):37.
PMID: 36804872 PMC: 9942322. DOI: 10.1186/s12933-023-01755-1.
Silva L, Gentil P, Seguro C, de Oliveira G, Silva M, Zamuner A Front Endocrinol (Lausanne). 2021; 12:760292.
PMID: 34858333 PMC: 8630737. DOI: 10.3389/fendo.2021.760292.
Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
Dhalla N, Shah A, Tappia P Int J Mol Sci. 2020; 21(7).
PMID: 32244448 PMC: 7177292. DOI: 10.3390/ijms21072413.
Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat.
Al Kury L, Smail M, Qureshi M, Sydorenko V, Shmygol A, Oz M J Diabetes Res. 2018; 2018:2974304.
PMID: 29850600 PMC: 5914098. DOI: 10.1155/2018/2974304.
Al Kury L, Sydorenko V, Smail M, Qureshi M, Shmygol A, Oz M Mol Cell Biochem. 2018; 446(1-2):25-33.
PMID: 29318456 DOI: 10.1007/s11010-018-3269-0.